Hans Christopher Toll
Finanzdirektor/CFO bei KAROLINSKA DEVELOPMENT AB
Ursprung des Netzwerks ersten Grades von Hans Christopher Toll
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Financial Conglomerates | 13 | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Hans Christopher Toll
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Investment Officer | |
| SINO BIOPHARMACEUTICAL LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal Chairman Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
Softhale NV
 Softhale NV Miscellaneous Commercial ServicesCommercial Services Softhale NV engages in manufacturing medical, clinical and pharmaceutical equipment. The company was founded by Jurgen Rawert and Frank Bartels and is headquartered in Diepenbeek, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Scibase AB | Director/Board Member Director/Board Member | ||
VOC Diagnostics AB
 VOC Diagnostics AB Medical/Nursing ServicesHealth Services VOC Diagnostics AB is a cancer diagnostics firm focusing on detection of ovarian cancer as a first indication. The company was founded by György Horvath in 2017 and is headquartered in Solna, Sweden. | Medical/Nursing Services | Chairman Chief Executive Officer | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Chief Executive Officer Director of Finance/CFO | |
| OSSDSIGN AB | Medical Specialties | Director/Board Member Director/Board Member | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Chief Executive Officer | |
| PROMIMIC AB | Medical Specialties | Corporate Officer/Principal Director/Board Member | |
| KD Incentive AB | Director/Board Member Director/Board Member | ||
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Svenska Vaccinfabriken Produktion AB
 Svenska Vaccinfabriken Produktion AB BiotechnologyHealth Technology Svenska Vaccinfabriken Produktion AB develops vaccines and immunotherapies to prevent and treat life-threatening diseases. The company is based in Stockholm, Sweden. The Swedish company was founded by Matti Sällberg, Margaret Chen, Jens Bäck, Lars Frelin. Richard Bethell has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Cure Cancer Foundation
 Cure Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Cure Cancer Foundation operates as a cancer care foundation. The private company is based in Austin, TX. | Miscellaneous Commercial Services | Director/Board Member | |
| AB INDUSTRIVÄRDEN | Financial Conglomerates | Corporate Officer/Principal | |
| ATTANA AB | Medical/Nursing Services | Director/Board Member | |
| DEDICARE AB | Other Consumer Services | Director/Board Member | |
| Insead Business School | College/University | Masters Business Admin | |
| Bambora Device AB | Director/Board Member | ||
| Stiftelsen Swecare | Director/Board Member | ||
Rsq Capital
 Rsq Capital Investment ManagersFinance Rsq Capital operates as a venture capital firm. The private company is based in Stockholm, Sweden. | Investment Managers | Private Equity Investor | |
Perma Ventures AB
 Perma Ventures AB Investment ManagersFinance Perma Ventures AB provides financial advisory services. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member | |
| POWERCELL SWEDEN AB | Alternative Power Generation | Director/Board Member | |
| AAC CLYDE SPACE AB | Telecommunications Equipment | Director/Board Member | |
The Journal of Clinical Investigation
 The Journal of Clinical Investigation Miscellaneous Commercial ServicesCommercial Services The Journal of Clinical Investigation is a private company headquartered in Ann Arbor, MI. The firm operates as non-profit organization of physician-scientists. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PharmAkea, Inc.
 PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
IMED AB
 IMED AB Drugstore ChainsRetail Trade IMED AB is focused on the development and commercialization of fully human monoclonal antibodies for treatment of immune disorders and diseases such as ischemia/reperfusion injury, HIV and cancer. IMED’s unique antibodies modulate the natural process of cell death called apoptosis by selective and specific blocking or induction of central signaling pathways. IMED AB is a privately owned biotechnology company funded by Karolinska Development and LinkMed AB and intends to out-license its products to pharmaceutical companies. | Drugstore Chains | Chief Executive Officer | |
Havgul Clean Energy AS
 Havgul Clean Energy AS Electric UtilitiesUtilities Havgul Clean Energy AS develops wind power projects. Its portfolio of projects includes Tonstad Wind Park, Kjølen Wind Park, E18 Wind Park and Siragrunnen Wind Park. The firm undertakes offshore and land based projects. The company was founded by Karl Hesstvedt, Harald Dirdal, Ketil Reed Aasgaard and Emil Torkildsen on December 1, 2007 and is headquartered in Oslo, Norway. | Electric Utilities | Private Equity Investor | |
| Arthur D. Little (Schweiz) AG | Corporate Officer/Principal | ||
Accenture (UK) Ltd.
 Accenture (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Accenture (UK) Ltd. provides strategy, consulting, outsourcing, and technology services. The company was founded on May 8, 2003 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Chalmers University of Technology | College/University | Graduate Degree | |
Fouriertransform AB
 Fouriertransform AB Investment ManagersFinance Fouriertransform AB (Fouriertransform) is a Swedish Government-owned venture capital firm which was established in 2008 to help strengthen the international competitiveness of the Swedish automotive cluster headquartered in Stockholm, the firm works in partnership with private enterprise and with VINNOVA (the Swedish Governmental Agency for Innovation Systems), ALMI Företagspartner AB and other partners. They aim to invest in businesses capable of contributing to the Swedish automotive industry and have a particular focus on environment and safety. | Investment Managers | Private Equity Investor | |
InnovationsKapital Nordic Advisors AB
 InnovationsKapital Nordic Advisors AB Investment ManagersFinance InnovationsKapital Nordic Advisors AB (InnovationsKapital) is a venture capital firm founded in 1994. The firm is headquartered in Gothenburg and Stockholm, Sweden. | Investment Managers | Corporate Officer/Principal | |
Biomatcell AB
 Biomatcell AB BiotechnologyHealth Technology Biomatcell AB operates as a holding company that commercializes inventions in the fields of biomaterial science and cell therapy by licensing its inventions and creating spin-off companies. It develops three-dimensional biomaterial scaffold geometries in bioactive ceramics and metals. It markets products and services based on research in the field of biomaterials and stem cells and patenting new ideas in the same area. The company was founded on May 11, 2004 and is headquartered in Gothenburg, Sweden. | Biotechnology | Director/Board Member | |
Accenture AB
 Accenture AB Miscellaneous Commercial ServicesCommercial Services Accenture AB provides information technology services. It offers the following activities: strategy, consulting, digital, technology, and operations. The company is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Arthur D Little AB | Corporate Officer/Principal | ||
| Star Syringe Ltd. | Director/Board Member | ||
Siemens AB
 Siemens AB Computer CommunicationsElectronic Technology Siemens AB provides solutions for infrastructure, energy technology, production, health, automation, and digitalization. It operates through the following business areas: Gas and Power, Smart Infrastructure, and Digital Industries. The company was founded in 1898 and is headquartered in Solna, Sweden. | Computer Communications | Director/Board Member | |
| RE:NEWCELL AB | Textiles | Director/Board Member | |
Origin Sciences Ltd.
 Origin Sciences Ltd. Medical SpecialtiesHealth Technology Origin Sciences Ltd. is a British company that is revolutionizing the treatment of gastrointestinal disease. The company is based in Great Abington, UK. The company specializes in taking samples of the gut for more accurate diagnostics. The company was founded in 2003. The CEO is Hugo Lywood. | Medical Specialties | Director/Board Member | |
| SMART EYE AB | Medical Specialties | Director/Board Member | |
Stiftelsen Bota Cancer
 Stiftelsen Bota Cancer Investment Trusts/Mutual FundsMiscellaneous Stiftelsen Bota Cancer operates a cancer foundation. The private company is based in Gothenburg, Sweden. | Investment Trusts/Mutual Funds | Director/Board Member | |
Anian AB
 Anian AB Miscellaneous Commercial ServicesCommercial Services Anian AB provides corporate consulting and securities brokerage services. The private company is based in Gronviksvagen, Sweden. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Schweden | 39 |
| Vereinigtes Königreich | 5 |
| Vereinigte Staaten | 4 |
| Hong Kong | 2 |
| Belgien | 2 |
Sektoral
| Health Technology | 16 |
| Commercial Services | 10 |
| Finance | 7 |
| Consumer Services | 5 |
| Health Services | 3 |
Operativ
| Director/Board Member | 105 |
| Corporate Officer/Principal | 35 |
| Chief Executive Officer | 29 |
| Chairman | 17 |
| Chief Tech/Sci/R&D Officer | 12 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Hans Christopher Toll
- Unternehmensverbindungen
